Connect with us
[the_ad id="89560"]

Health

Medical organizations and media let Canadians believe gender medicine is safe and universally accepted. It’s not

Published

9 minute read

Macdonald-Laurier Institute The Macdonald Laurier Institute

14 physicians sign statement for Inside Policy

Many Canadians are likely unaware that several other medically advanced countries—like Britain and multiple EU member states—have restricted hormone therapies and surgical interventions which have documented harms and no clear benefits, writes a group of Canadian doctors.

Following similar actions by peer countries around the world, United States President Donald Trump signed a Jan. 28 executive order declaring his administration will not “fund, sponsor, promote, assist, or support” so-called “gender-affirming” medical treatment for minors—which prescribes hormone therapies and surgical interventions that change sex-determined physical characteristics. Now, a recent report from the U.S. Department of Health and Human Services confirms what many other medical bodies and advanced countries have already recognized: the science and reasoning behind this form of medicine is deeply flawed.

This news appears shocking to many ordinary Canadians, as well as legacy media outlets like The Globe and Mail. That’s largely because Canadian medical organizations and governing bodies—presumed by the public to speak for physicians—have vocally supported “affirmation”: an approach that unquestioningly supports the choice of patients to undergo these treatments. This has left the public with the false impression that such treatments are safe, effective, and universally accepted by physicians. We, a group of 14 Canadian physicians, feel it is vital for the public to know that many—and perhaps most—physicians believe there must be restrictions on gender therapies that permanently change a minor’s body.

Many Canadians are likely unaware that similar restrictive policies are already in place in other medically advanced countries, like Britain and several EU member states.

Most notably, the U.K. government commissioned Dr. Hilary Cass to produce what has become known as the Cass Report, a thorough review of the literature around the treatment for gender dysphoria. Cass investigated whether there is actually proof that these therapies “save lives,” as many activists will insist, or if there is evidence that such interventions make patients’ lives better? Dr. Cass concluded that although medical treatments for gender dysphoria can cause significant harm (as is the case with any medical intervention), there is no conclusive proof of benefit. Hormone therapy and surgeries can lead to chronic pain, incontinence, sterility, and more. They are permanent and irreversible. Therefore, Britain and many other countries restrict most of these treatments for minors.

Here in Canada, Alberta has been the leader in following the evidence. In 2024, the province introduced legislation mandating a minimum age before children could consent to make these permanent, life-altering changes to their bodies. Many physicians were involved with drafting the well-considered legislation. Many more applauded it—some publicly, others quietly.

Despite that, the usual suspects leapt forward to pillory Premier Danielle Smith’s government. The CBC, Globe and Mail, and other legacy media outlets ran headlines like: “Medical experts warn Danielle Smith’s restrictions on gender affirming care will harm vulnerable youth in Alberta.” Most articles quoted bodies such as the Alberta Medical Association (AMA), Canadian Pediatric Society (CPS), and the venerable Canadian Medical Association (CMA), all of which very quickly released statements decrying Alberta’s stance. Such articles give the public the impression that these organizations speak for physicians, expressing a majority, if not unanimous, view.

These organizations do not speak for all physicians. It is hard to know what percentage of physicians oppose “gender-affirming care” for minors because many are afraid to speak their minds in a climate where any dissent is couched as “transphobia.” Physicians who speak out have been subject to investigations and penalties by regulatory organizations, particularly after the passing of federal Bill C-4 in 2022, which potentially makes it a criminal offence to refuse support of a child’s belief that he or she is transgender.

In 2025, one needs to take statements from physicians’ groups with a grain of salt.

Engagement with the CMA is in decline. In 2018 (when membership remained mandatory for doctors in many provinces), the association claimed 87,000 members. By 2024, membership dropped to 75,000 despite an increase in the number of physicians in Canada. Many are members only in a nominal sense, and have little meaningful involvement with the CMA. Rather than taking the pulse of the medical profession as a whole, seeking diverse viewpoints, and making statements that represent this range of views, the CMA is captured and directed by a radical progressive fringe. Unfortunately, this fringe retains the historical imprimatur of being the “voice of physicians” in Canada.

The same phenomenon has occurred with provincial physicians’ organizations like the AMA, which collect mandatory dues but seek minimal engagement from members. Activists have exploited this vacuum to take the helm of these organizations.

This same phenomenon can be seen in organizations like the CPSCMA, and similar specialty bodies. Their mission statements and missives  increasingly read like Marxist screeds rather than wise and measured comment.  Just one such example is the CMA’s “ReconciliACTION Plan,” which “challenges anti-Indigenous structures in the health care system.” When physicians with more conservative and scientifically-based views attempt to engage these groups, they have often been met with indifference or hostility, and are systematically prevented from holding positions within these organizations.

This shows that these organizations do not speak for all physicians. When mainstream media rely on such organizations as their sole source for “expert” comment, they miss the real story and avoid engaging with facts. Legacy media portrays this as a battle between science-denying right-wing bigots on one side, and empathetic experts on the other. This could not be further from the truth.

The science is not “settled” by any means. So-called “gender-affirming care” has proven risks and harms, but unproven benefits. It is not “life-saving,” but it is permanently life-altering. We are 14 of the many physicians who strongly believe that minors should not be allowed to make such decisions. The self-proclaimed “experts” do not speak for us.

Written and signed by,

Dr. Arney Lange MSc, MD, FRCPC
Dr. Brent McGrath, MD, FRCPC
Dr. Chris Millburn MD
Dr. David Zitner MD
Dr. Dion Davidson MD, FRCSC, FACS
Dr. Duncan Veasey MD
Dr. Julie Curwin MD FRCPC
Dr. Lori Regenstreif MD, CCFP (AM), FCFP
Dr. Mark D’Souza MD, CCFP (EM), FCFP
Dr. Martha Fulford MD, FRCPC
Dr. M.J. Ackermann MD
Dr. Richard Gibson MD, FCFP
Dr. Roy Eappen MDCM, FRCP (C)
Dr. Shawn Whatley MD, FCFP (EM)

This statement is an initiative of the Macdonald-Laurier Institute, written and signed by concerned physicians from across Canada who are calling for a more careful, evidence-based, and ethically responsible approach to the treatment of gender issues.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

RFK Jr. planning new restrictions on drug advertising: report

Published on

MXM logo MxM News

Quick Hit:

The Trump administration is reportedly weighing new restrictions on pharmaceutical ads—an effort long backed by Health Secretary Robert F. Kennedy Jr. Proposals include stricter disclosure rules and ending tax breaks.

Key Details:

  • Two key proposals under review: requiring longer side-effect disclosures in TV ads and removing pharma’s tax deduction for ad spending.

  • In 2024, drug companies spent $10.8 billion on direct-to-consumer ads, with AbbVie and Pfizer among the top spenders.

  • RFK Jr. and HHS officials say the goal is to restore “rigorous oversight” over drug promotions, though no final decision has been made.

Diving Deeper:

According to a Bloomberg report, the Trump administration is advancing plans to rein in direct-to-consumer pharmaceutical advertising—a practice legal only in the U.S. and New Zealand. Rather than banning the ads outright, which could lead to lawsuits, officials are eyeing legal and financial hurdles to limit their spread. These include mandating extended disclosures of side effects and ending tax deductions for ad spending—two measures that could severely limit ad volume, especially on TV.

Health and Human Services Secretary Robert F. Kennedy Jr., who has long called for tougher restrictions on drug marketing, is closely aligned with the effort. “We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,” said HHS spokesman Andrew Nixon in a written statement. Kennedy himself told Sen. Josh Hawley in May that an announcement on tax policy changes could come “within the next few weeks.”

The ad market at stake is enormous. Drugmakers spent $10.8 billion last year promoting treatments directly to consumers, per data from MediaRadar. AbbVie led the pack, shelling out $2 billion—largely to market its anti-inflammatory drugs Skyrizi and Rinvoq, which alone earned the company over $5 billion in Q1 of 2025.

AbbVie’s chief commercial officer Jeff Stewart admitted during a May conference that new restrictions could force the company to “pivot,” possibly by shifting marketing toward disease awareness campaigns or digital platforms.

Pharma’s deep roots in broadcast advertising—making up 59% of its ad spend in 2024—suggest the impact could be dramatic. That shift would mark a reversal of policy changes made in 1997, when the FDA relaxed requirements for side-effect disclosures, opening the floodgates for modern TV drug commercials.

Supporters of stricter oversight argue that U.S. drug consumption is inflated because of these ads, while critics warn of economic consequences. Jim Potter of the Coalition for Healthcare Communication noted that reinstating tougher ad rules could make broadcast placements “impractical.” Harvard professor Meredith Rosenthal agreed, adding that while ads sometimes encourage patients to seek care, they can also push costly brand-name drugs over generics.

Beyond disclosure rules, the administration is considering changes to the tax code—specifically eliminating the industry’s ability to write off advertising as a business expense. This idea was floated during talks over Trump’s original tax reform but was ultimately dropped from the final bill.

Continue Reading

Alberta

Alberta pro-life group says health officials admit many babies are left to die after failed abortions

Published on

From LifeSiteNews

By Anthony Murdoch

Alberta’s abortion policy allows babies to be killed with an ‘induced cardiac arrest’ before a late-term abortion and left to die without medical care if they survive.

A Canadian provincial pro-life advocacy group says health officials have admitted that many babies in the province of Alberta are indeed born alive after abortions and then left to die, and because of this are they are calling upon the province’s health minister to put an end to the practice.

Official data from the Canadian Institute for Health Information (CIHI), which is the federal agency in charge of reporting the nation’s health data, shows that in Alberta in 2023-2024, there were 133 late-term abortions. Of these, 28 babies were born alive after the abortion and left to die.

As noted by Prolife Alberta’s President Murray Ruhl in a recent email, this means the reality in the province is that “some of these babies are born alive… and left to die.”

“Babies born alive after failed late-term abortions are quietly abandoned—left without medical help, comfort, or even a chance to survive,” noted Ruhl.

This fact was brought to light in a recent opinion piece published in the Western Standard by Richard Dur, who serves as the executive director of Prolife Alberta.

Ruhl observed that Dur’s opinion piece has “got the attention of both Alberta Health Services (AHS) and Acute Care Alberta (ACA),” whom he said “confirmed many of the practices we exposed.”

Alberta’s policy when it comes to an abortion committed on a baby older than 21 weeks allows that all babies are killed before being born, however this does not always happen.

“In some circumstances… the patient and health practitioner may consider the option of induced fetal cardiac arrest prior to initiating the termination procedures,” notes Alberta Health Services’ Termination of Pregnancy, PS-92 (PS-92, Section 6.4).

Ruhl noted that, in Alberta, before an “abortion begins, they stop the baby’s heart. On purpose. Why? Because they don’t want a live birth. But sometimes—the child survives. And what then?”

Ruhl observed that the reality is, “They plan in advance not to save her—even if she’s born alive.”

If the baby is born alive, the policy states, “Comfort measures and palliative care should be provided.” (PS-92, Section 6.4).

This means, however, that there is no oxygen given, no NICU, “no medical care,” noted Ruhl.

“Their policies call this ‘palliative care.’ We call it what it is: abandonment. Newborns deserve care—not a death sentence,” he noted.

As reported by LifeSiteNews recently, a total of 150 babies were born after botched abortions in 2023-2024 in Canada. However, it’s not known how many survived.

Only two federal parties in Canada, the People’s Party of Canada, and the Christian Heritage Party, have openly called for a ban on late abortions in the nation.

Policy now under ‘revision’ says Alberta Health Services

Ruhl said that the province’s policies are now “under revision,” according to AHS.

Because of this, Ruhl noted that now is the time to act and let the province’s Health Minister, Adriana LaGrange, who happens to be pro-life, act and “demand” from her real “action to protect babies born alive after failed abortions.”

The group is asking the province to do as follows below:

  1. Amend the AHS Termination of Pregnancy policy to require resuscitative care for any baby born with signs of life, regardless of how the birth occurred.
  2. Require that these newborns receive the same level of care as any other premature baby. Newborns deserve care—not a death sentence.
  3. Recognize that these babies have a future—there is a literal waiting list of hundreds of families ready to adopt them. There is a home for every one of them.

While many in the cabinet and caucus of Alberta Premier Danielle Smith’s United Conservative government are pro-life, she has still been relatively soft on social issues of importance to conservatives, such as abortion.

Continue Reading

Trending

X